Esophagus News

Children and adolescents with documented postacute COVID-19 syndrome experienced increased risk for gastrointestinal symptoms and disorders, according to a study published in JAMA Open Network.

A methylation biomarker panel paired with a minimally invasive sponge-capsule device identified Barrett’s esophagus, esophageal adenocarcinoma and high-grade dysplasia, according to a study published in American Journal of Gastroenterology.

SAN DIEGO — Treatment for eosinophilic esophagitis often involves collaboration between specialists, but patients face challenges in adherence, according to a pair of posters presented here.

SAN DIEGO — Adolescents and adults with eosinophilic esophagitis improved with dupilumab regardless of whether they were practicing food elimination diets during treatment, according to a poster presented here.

In this podcast episode, Prateek Sharma, MD, about how program directors can help shepherd GI fellows into clinical research spaces, providing quality exams for upper endoscopy and more.

Considering “paradigm-shifting changes” in the diagnosis and management of eosinophilic esophagitis, the ACG released an updated guideline on treatment, monitoring and maintenance as well as pediatric-specific recommendations.

Having GERD, diabetes or osteoporosis in addition to COPD heightened the likelihood for exacerbations, ED visits and hospitalizations, according to results published in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation.

To honor GERD Awareness Week on Nov. 24 to 30, the International Foundation for Gastrointestinal Disorders launched a campaign theme, “Relief Starts with Awareness,” to boost understanding of symptoms and treatments for the disease.

PHILADELPHIA — On-demand vonoprazan effectively reduced heartburn symptom severity in patients with nonerosive reflux disease within 1 hour of treatment, according to data presented at the ACG Annual Scientific Meeting.